Supernus Pharmaceuticals, Inc. (SUPN)

47.76 -1.08 (-2.21%) USD  |  NASDAQ  |  Mar 20, 16:00
47.74 -0.02 (-0.03%) After-Hours: 20:00
More

Supernus Pharmaceuticals EPS LT Growth Estimates

EPS LT Growth Estimates Chart

View EPS LT Growth Estimates for SUPN.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS LT Growth Estimates Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EPS LT Growth Estimates Range, Past 5 Years

View EPS LT Growth Estimates Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS LT Growth Estimates Benchmarks

View EPS LT Growth Estimates Benchmarks
Start Trial
Biogen, Inc. Upgrade
BridgeBio Pharma, Inc. --
Corcept Therapeutics, Inc. Upgrade
Catalyst Pharmaceuticals, Inc. Upgrade
Cytokinetics, Inc. Upgrade